STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma: Laboratory investigation

Journal of Neurosurgery

Volumn 121, Issue 2, 2014, Pages 374-383

  Thota, Balaram ^a   Arimappamagan, Arivazhagan ^a   Kandavel, Thennarasu ^a   Shastry, Arun H ^a   Pandey, Paritosh ^a   Chandramouli, Bangalore Ashwathnarayanarao ^a   Hegde, Alangar Sathyaranjandas ^b   Kondaiah, Paturu ^c   Santosh, Vani ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b SRI SATHYA SAI INSTITUTE OF HIGHER MEDICAL SCIENCES   (India)

^c INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Biomarker; Glioblastoma; IGFBP 3; Oncology; Prognosis; STAT 1

Indexed keywords

BIOLOGICAL MARKER; SHORT HAIRPIN RNA; SOMATOMEDIN BINDING PROTEIN 3; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; GENE SILENCING; GLIOBLASTOMA; GLIOMA CELL; GLIOMA CELL LINE; HAZARD RATIO; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MOLECULAR BIOLOGY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; AGED; BIOSYNTHESIS; BRAIN TUMOR; CELL MOTION; FEMALE; GENETICS; GLIOMA; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; SURVIVAL; TUMOR CELL LINE;

ADULT; AGED; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; STAT1 TRANSCRIPTION FACTOR; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84905437591     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2014.4.JNS131198     Document Type: Article

References (59)

1. Arany I, Chen SH, Megyesi JK, Adler-Storthz K, Chen Z, Rajaraman S, et al: Differentiation-dependent expression of signal transducers and activators of transcription (STATs) might modify responses to growth factors in the cancers of the head and neck. Cancer Lett 199:83-89, 2003 (Pubitemid 37088141)
2. Battle TE, Wierda WG, Rassenti LZ, Zahrieh D, Neuberg D, Kipps TJ, et al: In vivo activation of signal transducer and activator of transcription 1 after CD154 gene therapy for chronic lymphocytic leukemia is associated with clinical and immunologic response. Clin Cancer Res 9:2166-2172, 2003 (Pubitemid 36687639)
3. Baxter RC: Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol Pathol 54:145-148, 2001
4. Benini S, Zuntini M, Manara MC, Cohen P, Nicoletti G, Nanni P, et al: Insulin-like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcoma. Int J Cancer 119:1039-1046, 2006 (Pubitemid 44116910)
5. Brivanlou AH, Darnell JE Jr: Signal transduction and the control of gene expression. Science 295:813-818, 2002 (Pubitemid 34118354)
6. Burger AM, Leyland-Jones B, Banerjee K, Spyropoulos DD, Seth AK: Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer. Eur J Cancer 41:1515-1527, 2005 (Pubitemid 40981832)
7. Ciampolillo A, De Tullio C, Giorgino F: The IGF-I/IGF-I receptor pathway: implications in the Pathophysiology of Thyroid Cancer. Curr Med Chem 12:2881-2891, 2005 (Pubitemid 41613364)
8. Coverley JA, Martin JL, Baxter RC: The effect of phosphorylation by casein kinase 2 on the activity of insulin-like growth factor-binding protein-3. Endocrinology 141:564-570, 2000 (Pubitemid 32250480)
9. Darnell JE Jr: STATs and gene regulation. Science 277:1630-1635, 1997
10. Duarte CW, Willey CD, Zhi D, Cui X, Harris JJ, Vaughan LK, et al: Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner. PLoS ONE 7:e29653, 2012
11. Efimova EV, Liang H, Pitroda SP, Labay E, Darga TE, Levina V, et al: Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling. Int J Radiat Biol 85:421-431, 2009
12. Firth SM, Baxter RC: Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854, 2002 (Pubitemid 35454590)
13. Firth SM, Baxter RC: Characterisation of recombinant glycosylation variants of insulin-like growth factor binding protein-3. J Endocrinol 160:379-387, 1999 (Pubitemid 29182829)
14. Fryknäs M, Dhar S, Oberg F, Rickardson L, Rydåker M, Göransson H, et al: STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines. Int J Cancer 120:189-195, 2007 (Pubitemid 44901935)
15. Fukushima T, Kataoka H: Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma. Anticancer Res 27 (6A):3685-3692, 2007 (Pubitemid 47598431)
16. Fuller GN, Rhee CH, Hess KR, Caskey LS, Wang R, Bruner JM, et al: Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res 59:4228-4232, 1999 (Pubitemid 29418733)
17. Giles ED, Singh G: Role of insulin-like growth factor binding proteins (IGFBPs) in breast cancer proliferation and metastasis. Clin Exp Metastasis 20:481-487, 2003 (Pubitemid 37297175)
18. Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delobel J, et al: STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood 87:1692-1697, 1996 (Pubitemid 26068885)
19. Gui Y, Murphy LJ: Interaction of insulin-like growth factor binding protein-3 with latent transforming growth factor-beta binding protein-1. Mol Cell Biochem 250:189-195, 2003 (Pubitemid 37045737)
20. Haybaeck J, Obrist P, Schindler CU, Spizzo G, Doppler W: STAT-1 expression in human glioblastoma and peritumoral tissue. Anticancer Res 27 (6B):3829-3835, 2007
21. Hintz RL, Bock S, Thorsson AV, Bovens J, Powell DR, Jakse G, et al: Expression of the insulin like growth factor-binding protein 3 (IGFBP-3) gene is increased in human renal carcinomas. J Urol 146:1160-1163, 1991
22. Hui Z, Tretiakova M, Zhang Z, Li Y, Wang X, Zhu JX, et al: Radiosensitization by inhibiting STAT1 in renal cell carcinoma. Int J Radiat Oncol Biol Phys 73:288-295, 2009
23. Jones JI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR: Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc Natl Acad Sci U S A 88:7481-7485, 1991 (Pubitemid 21915176)
24. Ju H, Li X, Li H, Wang X, Wang H, Li Y, et al: Mediation of multiple pathways regulating cell proliferation, migration, and apoptosis in the human malignant glioma cell line U87MG via unphosphorylated STAT1. Laboratory investigation. J Neurosurg 118:1239-1247, 2013
25. Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, et al: Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 28:619-637, 1996 (Pubitemid 26174707)
26. Khodarev NN, Beckett M, Labay E, Darga T, Roizman B, Weichselbaum RR: STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci U S A 101:1714-1719, 2004 (Pubitemid 38234220)
27. Khodarev NN, Minn AJ, Efimova EV, Darga TE, Labay E, Beckett M, et al: Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells. Cancer Res 67:9214-9220, 2007 (Pubitemid 47535908)
28. Khodarev NN, Roach P, Pitroda SP, Golden DW, Bhayani M, Shao MY, et al: STAT1 pathway mediates amplification of metastatic potential and resistance to therapy. PLoS ONE 4:e5821, 2009
29. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-229, 2002
30. Kleihues P, Louis DN, Wiestler OD, Burger PC, Schiethauer BW: WHO grading of tumors of central nervous system, in Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds): WHO Classification of Tumors of the Central Nervous System, ed 4. Lyon: IARC Press, 2007, pp 10-11
31. Kovacic B, Stoiber D, Moriggl R, Weisz E, Ott RG, Kreibich R, et al: STAT1 acts as a tumor promoter for leukemia development. Cancer Cell 10:77-87, 2006
32. Kulkarni A, Thota B, Srividya MR, Thennarasu K, Arivazhagan A, Santosh V, et al: Expression pattern and prognostic significance of IGFBP isoforms in anaplastic astrocytoma. Pathol Oncol Res 18:961-967, 2012
33. Marinaro JA, Neumann GM, Russo VC, Leeding KS, Bach LA: O-glycosylation of insulin-like growth factor (IGF) binding protein-6 maintains high IGF-II binding affinity by decreasing binding to glycosaminoglycans and susceptibility to proteolysis. Eur J Biochem 267:5378-5386, 2000
34. Martin JL, Weenink SM, Baxter RC: Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases. J Biol Chem 278:2969-2976, 2003 (Pubitemid 36801203)
35. Massoner P, Colleselli D, Matscheski A, Pircher H, Geley S, Jansen Dürr P, et al: Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility. Endocr Relat Cancer 16:795-808, 2009
36. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63, 1983
37. Natsuizaka M, Ohashi S, Wong GS, Ahmadi A, Kalman RA, Budo D, et al: Insulin-like growth factor-binding protein-3 promotes transforming growth factor-beta1-mediated epithelial-to-mesenchymal transition and motility in transformed human esophageal cells. Carcinogenesis 31:1344-1353, 2010
38. Oh SH, Lee OH, Schroeder CP, Oh YW, Ke S, Cha HJ, et al: Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibition. Mol Cancer Ther 5:2685-2695, 2006 (Pubitemid 44848995)
39. O'Shea JJ, Gadina M, Schreiber RD: Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109 (Suppl):S121-S131, 2002 (Pubitemid 34457857)
40. Oy GF, Slipicevic A, Davidson B, Solberg Faye R, Maelandsmo GM, Flørenes VA: Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma. Int J Cancer 126:350-361, 2010
41. Ragel BT, Couldwell WT, Gillespie DL, Jensen RL: Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. Neurosurg Rev 30:181-187, 2007 (Pubitemid 46897342)
42. Rajah R, Valentinis B, Cohen P: Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 272:12181-12188, 1997 (Pubitemid 27202802)
43. Reddy SP, Britto R, Vinnakota K, Aparna H, Sreepathi HK, Thota B, et al: Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis. Clin Cancer Res 14:2978-2987, 2008
44. Riedemann J, Macaulay VM: IGF1R signalling and its inhibition. Endocr Relat Cancer 13 (Suppl 1):S33-S43, 2006 (Pubitemid 46219247)
45. Rosenfeld RG, Hwa V, Wilson E, Plymate SR, Oh Y: The insulin-like growth factor-binding protein superfamily. Growth Horm IGF Res 10 Suppl A:S16-S17, 2000
46. Santosh V, Arivazhagan A, Sreekanthreddy P, Srinivasan H, Thota B, Srividya MR, et al: Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma. Cancer Epidemiol Biomarkers Prev 19:1399-1408, 2010
47. Sheen-Chen SM, Huang CC, Tang RP, Yang CH, Chou FF, Eng HL: Signal transducer and activator of transcription 1 in breast cancer: analysis with tissue microarray. Anticancer Res 27 (4B):2481-2486, 2007 (Pubitemid 47228092)
48. Sivaprasad U, Fleming J, Verma PS, Hogan KA, Desury G, Cohick WS: Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells. Endocrinology 145:4213-4221, 2004 (Pubitemid 39120570)
49. Spagnoli A, Torello M, Nagalla SR, Horton WA, Pattee P, Hwa V, et al: Identification of STAT-1 as a molecular target of IGFBP-3 in the process of chondrogenesis. J Biol Chem 277:18860-18867, 2002 (Pubitemid 34952445)
50. Sreekumar A, Nyati MK, Varambally S, Barrette TR, Ghosh D, Lawrence TS, et al: Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. Cancer Res 61:7585-7593, 2001 (Pubitemid 32995052)
51. Stark GR: How cells respond to interferons revisited: from early history to current complexity. Cytokine Growth Factor Rev 18:419-423, 2007
52. Takaoka M, Harada H, Andl CD, Oyama K, Naomoto Y, Dempsey KL, et al: Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3. Cancer Res 64:7711-7723, 2004 (Pubitemid 39446902)
53. Torng PL, Lee YC, Huang CY, Ye JH, Lin YS, Chu YW, et al: Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma. Oncogene 27:2137-2147, 2008
54. Trojan J, Cloix JF, Ardourel MY, Chatel M, Anthony DD: Insulin-like growth factor type I biology and targeting in malignant gliomas. Neuroscience 145:795-811, 2007 (Pubitemid 46441671)
55. Vincent AM, Feldman EL: Control of cell survival by IGF signaling pathways. Growth Horm IGF Res 12:193-197, 2002 (Pubitemid 35230190)
56. Wang H, Fuller GN, Zhang W: Insulin-like growth factors and insulin-like growth factor binding proteins in CNS tumors, in Zhang W, Fuller GN (eds): Genomic and Molecular Neuro-Oncology. Sudbury, MA: Jones and Bartlett, 2004, pp 119-130
57. Widschwendter A, Tonko-Geymayer S, Welte T, Daxenbichler G, Marth C, Doppler W: Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer. Clin Cancer Res 8:3065-3074, 2002 (Pubitemid 35155015)
58. Xi S, Dyer KF, Kimak M, Zhang Q, Gooding WE, Chaillet JR, et al: Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis. J Natl Cancer Inst 98:181-189, 2006 (Pubitemid 43205480)
59. Xi Y, Nakajima G, Hamil T, Fodstad O, Riker A, Ju J: Association of insulin-like growth factor binding protein-3 expression with melanoma progression. Mol Cancer Ther 5:3078-3084, 2006 (Pubitemid 46092049)